PupillOmetry for Prediction of DelirIUM

NCT ID: NCT05248035

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

213 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-15

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Delirium in intensive care unit (ICU) is a serious event. It is associated with short-term complications (agitation, self-extubation, accidental removal of catheters, prolonged length of stay and ventilation), excess mortality, functional and cognitive impairment. It is particularly frequent in patients requiring mechanical ventilation but diagnosis is not easy. There are screening scales, but it is insufficiently used in clinical practice: Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Intensive Care Delirium Screening Checklist (ICDSC). These scales are time consuming and require trained personnel. Automated pupillometry (AP) is a new device to objectively, rapidly, and reproducibly identify acute brain dysfunction. Recent data suggest that AP could be used to predict delirium in the ICU. This would need to be validated for routine use in the ICU.

Evaluate AP parameters on day 3 of invasive mechanical ventilation as a predictive tool for CAM-ICU diagnosed delirium during the first 14 days of ICU stay.

Study design: Prospective, multicenter, non-interventional cohort

Measurement of the AP parameters at day 3 after ICU admission and their predictive performance for delirium: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Automated pupillometry is an easy-to-use device that allows for accurate objective assessment of the photomotor reflex.

AP it allows the acquisition of dynamic parameters in addition to pupillary diameter, such as quantitative measurement of pupillary reactivity, speed, or latency of pupil contraction after a standardized light stimulus.

Automated pupillometry has been evaluated in ICU, in a monocentric study in non-brain-damaged patients, AP was used for the first time to predict the occurrence of delirium. Interestingly, the decrease in pupillary diameter variation at day 0 after 48h of IMV (D0) was independently associated with the occurrence of delirium during the ICU stay. This seems promising but requires a validation study in order to recommend its routine use.

The hypothesis is the AP parameters predict the risk of delirium in ICU-patients ventilated for more than 48 hours. Specifically, AP parameters on the D3 of mechanical ventilation allow predicting the occurrence of delirium during the first 14 days of resuscitation. This will allow early change of patient management, by identifying patients at risk of delirium and serious short-term adverse events.

This is a prospective, observational, multicenter cohort study involving 5 ICU in the Paris area.

To ensure the 213 planned inclusions and the 3-month follow-up of all included patients, a research duration of 15 months is expected. The ethical committee of the French Society of intensive care medicine (FICS) approved the study protocol (CE SRLF 20-09) and required Family members' informed consent.

At D0, patient is included and we start to evaluate AP parameter twice a day from D0 to D7 and to monitor delirium occurrence using Confusion assessment monitoring in the ICU (CAM ICU).

We assess changes in AP parameters from D0 to D7 of mechanical ventilation in patients with and without CAM-ICU diagnosed delirium during the first 14 days of ICU stay.

Automated pupillometry protocol : The AP is measured for each eye from D0 onwards, twice a day, as long as the patient is under mechanical ventilation and up to a maximum of 7 days (D7), using the NPI Neuroptics® device. These parameters were measured by the nurses or by the investigating physician not involved in the patient's care. At each measurement point, the mean value of both eyes was used for the analyses. The AP parameters are: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses. Routine neurological monitoring in ICU includes the RASS score every 4 hours. If the RASS score is ≥ -3 then CAM-ICU will be administered twice daily starting on day 3 by the patient's attending physicians. The physicians in charge of the patient will be blinded to the AP results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delirium ICU

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient

Adult patient hospitalized in ICU for a duration of mechanical ventilation longer than 48 hours

Adult patient hospitalized in ICU

Intervention Type OTHER

acquisition of dynamic parameters in addition to pupillary diameter, such as . pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses after a standardized light stimulus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adult patient hospitalized in ICU

acquisition of dynamic parameters in addition to pupillary diameter, such as . pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses after a standardized light stimulus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults ≥ 18 years
* mechanical ventilation since 48h
* Information and no opposition of patient or close person if he is present at the time of inclusion, otherwise urgent inclusion

Exclusion Criteria

* Patient diagnosed confused by CAM-ICU on D0
* Ophthalmological pathology modifying the photomotor reflex
* Acute or chronic neurological pathology: Cerebro-injured patients (head trauma, stroke, cardiopulmonary arrest, hypoglycemic coma, meningitis / encephalitis / brain abscess), dementia with MMSE \<24
* Duration of stay in intensive care\> 72h or duration of ventilation\> 72h
* Readmission in intensive care
* Moribund patient
* Patient under guardianship or curatorship
* No affiliation to social security (beneficiary or assignee)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre Jaquet, MD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Bichat-Claude Bernard

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Jaquet P, Couffignal C, Tardivon C, Godard V, Bellot R, Assouline B, Benghanem S, Da Silva D, Decavele M, Dessajan J, Hermann B, Rambaud T, Voiriot G, Sonneville R; PODIUM Study Group. PupillOmetry for preDIction of DeliriUM in ICU (PODIUM): protocol for a prospective multicentre cohort study. BMJ Open. 2023 Jul 12;13(7):e072095. doi: 10.1136/bmjopen-2023-072095.

Reference Type DERIVED
PMID: 37438060 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A03517-32

Identifier Type: OTHER

Identifier Source: secondary_id

APHP201165

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prognosis of Brain Reflexes
NCT02395861 UNKNOWN NA